[New diagnostic method in pulmonary carcinoid].
In clinical oncology tumor markers could be helpful in diagnostics, and may play a complementary role beside the imaging systems in the follow up of patients with malignant disease. Chromogranin A can be considered as a marker in neuroendocrine malignancies such as pulmonary carcinoids. Based on recommendations adopted from the literature, the authors measured chromogranin A levels in sera of patients with carcinoid tumors of different stages. Although the patient number is low, our data suggest that in cases where carcinoid metastasis can be detected, chromogranin A levels are elevated.
Csiszér
Eszter
E
Országos Korányi Tbc és Pulmonológiai Intézet, Budapest, Hungary. csiszer@koranyi.hu
Antus
Balázs
B
Himber
Gabriella
G
Hertel
Katalin
K
Fillinger
János
J
D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood*; D002276:Carcinoid Tumor / Q000097:blood / Q000175:diagnosis* / Q000556:secondary; D053379:Chromogranin A / Q000097:blood*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging
D014408:Biomarkers, Tumor; D053379:Chromogranin A